3046 POSTER A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line therapy in patients with metastatic colorectal cancer
T.E. Ciuleanu, W. Scheithauer, G. Kurteva, J. Ocvirk, I. Koza, D. Papamichael, M. Wenczl, T. Brodowicz, C.C. Zielinski, S. BeslijaVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70974-6
File:
PDF, 55 KB
english, 2007